Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleEfficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsMichael Rothkopf